Latest News

Bachem Holding (SWX:BANB) has just wrapped up FY 2025 with second half revenue of CHF 382.1 million and basic EPS of CHF 1.31, alongside trailing twelve month revenue of CHF 695.1 million and EPS of CHF 1.98 that sit against a 23.7% earnings growth figure for the year. The company has seen revenue move from CHF 605.3 million to CHF 695.1 million on a trailing basis, while EPS has shifted from CHF 1.60 to CHF 1.98. This sets up a story of higher sales translating into improved earnings per...

Recent performance snapshot and why Starbucks is on investors’ radar Starbucks (SBUX) has drawn fresh attention after a mixed run in the stock, with a 1.3% decline over the past day and a 2.0% dip over the past week, contrasting with gains over the past month and past 3 months. Against that backdrop, the company’s latest reported annual figures show revenue of US$37.7b and net income of US$1.4b, with year on year revenue growth of 4.4% and net income growth of 29.1%. See our latest analysis...

Shanghai Chicmax Cosmetic Co., Ltd. previously issued unaudited guidance for 2025, indicating expected revenue of about RMB 9,100.0 million to RMB 9,200.0 million and profit of roughly RMB 1,140.0 million to RMB 1,160.0 million, both showing strong year-on-year increases versus 2024. The company linked this outlook to the effectiveness of its multi-brand, multi-category approach, highlighting especially strong momentum from its KANS anti-aging skincare line and its infant-focused newpage...

Motorola Solutions (MSI) is back on investors’ radar after the board expanded to add software and cybersecurity veteran Peter Leav, along with the recent Exacom acquisition that deepens its focus on mission-critical public safety technology. See our latest analysis for Motorola Solutions. The recent 2.8% 7 day share price return and 1.9% 30 day share price return have come alongside the Exacom deal and Peter Leav’s board appointment. A 29.4% 90 day share price return and 12.6% 1 year total...

LyondellBasell recently announced that David Dennison, a nearly 30‑year industry veteran who joined the company in 2007 and most recently served as a vice president in its Circular and Low Carbon Solutions business, will become head of investor relations in May 2026, succeeding retiring long‑time executive Dave Kinney. Dennison’s background in planning, commercial leadership and circular solutions could meaningfully shape how LyondellBasell communicates its transition toward recycling,...

In early March 2026, AvePoint announced the past general availability of its AgentPulse Command Center, expanding multicloud observability and governance for autonomous AI agents across Microsoft 365 and Google Cloud, with unified monitoring, lifecycle management, and cost controls to reduce shadow AI, data exposure, and surprise usage bills. A distinctive feature is the single-pane view across Copilot Studio, Microsoft Foundry, SharePoint agents, and Vertex AI, giving enterprises...

Reit 1 (TASE:RIT1) has released its FY 2025 numbers with fourth quarter revenue of ₪91.1 million and basic EPS of ₪0.89, alongside trailing twelve month EPS of ₪2.53 on revenue of ₪509.9 million. Over the past year, the company has reported profit growth of 69.9% and a net profit margin of 97.5% compared with 59.8% in the prior year, supported in part by a ₪251.2 million one off gain. These results frame a reporting period in which investors may focus on how sustainable these margins are. See...

Live Nation Entertainment has settled the US Department of Justice’s antitrust lawsuit without admitting wrongdoing, extending its consent decree by eight years and setting up a US$280 million fund to address state damages claims. The agreement lets Live Nation retain Ticketmaster under stricter operating conditions while leaked internal messages and ongoing state actions keep its ticketing practices under intense scrutiny. We’ll now examine how the extended DOJ consent decree and continuing...

In early March 2026, Incyte reported a U.S. FDA Complete Response Letter for an additional lung cancer indication of Zynyz due to compliance issues at a third‑party fill‑finish facility, while also securing European Commission approval for Zynyz in combination with chemotherapy as a first‑line treatment for advanced anal cancer. The contrast between a regulatory setback tied to a partner’s manufacturing site in the U.S. and a fresh approval expanding Zynyz’s reach in Europe underscores how...

Frontdoor (FTDR) is back in focus after reporting Q4 revenue of $433 million, a 13.1% year over year increase, along with earnings that exceeded expectations and full year revenue guidance slightly below projections. See our latest analysis for Frontdoor. Since the earnings release, Frontdoor’s share price has moved to US$64.22, with a 13.38% 1 month share price return and a 69.58% 1 year total shareholder return, which may suggest building momentum despite some recent short term pullback. If...

In March 2026, Oklo Inc. and Centrus Energy agreed to pursue a joint venture for high-assay low-enriched uranium deconversion at Centrus’ Piketon, Ohio site, while Centrus also reported lower-than-expected quarterly earnings affected by a delayed Russian shipment and outlined increased capital spending plans. Centrus’ recent collaboration with Palantir on AI-driven enrichment optimization and its talks with Oklo on an integrated HALEU hub highlight how technology and fuel-cycle partnerships...

Wondering if United Bankshares at around US$39.38 is still a fair deal or starting to look stretched? This article breaks down what the current share price might be implying about value. The stock’s returns range from a 1.4% decline over the last 7 days and a 10.7% decline over the last 30 days, to gains of 2.6% year to date, 17.5% over 1 year, 25.7% over 3 years and 25.2% over 5 years. These figures can mean very different things depending on how you think about risk and timing. Recent...

Why Zealand Pharma stock is in focus after new obesity trial data Zealand Pharma (CPSE:ZEAL) has moved into the spotlight after announcing that its investigational obesity therapy petrelintide met the primary endpoint in a large Phase 2 trial, showing statistically significant weight loss versus placebo. See our latest analysis for Zealand Pharma. The positive petrelintide data arrives after a difficult period for Zealand Pharma shareholders. A 30 day share price return of 29.15% and a 90 day...

Nebius Group (NasdaqGS:NBIS) has signed a multi year AI infrastructure supply agreement with Meta Platforms valued at $27b. The deal spans five years and involves providing dedicated GPU capacity using NVIDIA's Vera Rubin platform across multiple global sites. The contract is described as one of the largest AI cloud agreements signed to date and secures Nebius a meaningful share of Meta's planned AI infrastructure spend. Nebius Group comes into this agreement with strong recent share price...

O'Reilly Automotive completed a significant fixed income offering of senior unsecured notes due in 2036. The transaction adds long dated debt to the company’s balance sheet, which may affect its capital structure and liquidity profile. The terms of the notes and investor demand can offer clues about how credit markets currently view O'Reilly Automotive, ticker NasdaqGS:ORLY. Investors watching NasdaqGS:ORLY now have a fresh data point to consider alongside the current share price of $90.46...

Dentsply Sirona and Siemens Healthineers recently received US FDA clearance for the MAGNETOM Free.Max Dental Edition, the first dental‑dedicated MRI system clinically validated for multiple specialties including endodontics, periodontics, TMJ, orthodontics, and tooth extraction. This non‑ionizing, dental‑specific MRI platform, with a focused field of view and sub‑20‑minute workflow, could meaningfully enhance complex diagnostic capabilities in hospitals, large clinics, and academic...

License extension with Dolce&Gabbana puts long-term brand access in focus EssilorLuxottica Société anonyme (ENXTPA:EL) has extended its license agreement with Dolce&Gabbana through 2050, keeping exclusive rights to develop, produce and distribute the fashion house’s prescription frames and sunglasses worldwide. For shareholders, this very long duration deal highlights the importance of licensed luxury brands within EssilorLuxottica’s eyewear mix. It also raises questions about how this...

Monte Rosa Therapeutics announced a past supply agreement with Johnson & Johnson under which Johnson & Johnson will provide ERLEADA (apalutamide) for a Monte Rosa–sponsored Phase 2 trial evaluating MRT-2359 in patients with metastatic castration-resistant prostate cancer (mCRPC) with androgen receptor mutations, with study initiation planned for the third quarter of 2026. This collaboration builds on encouraging early clinical data for MRT-2359 plus enzalutamide and highlights growing...

Lakshmi Mittal plans to retire from the Goldman Sachs Group (NYSE:GS) Board of Directors at the 2026 Annual Meeting. The decision follows the company’s age-based retirement policy, as confirmed by a recent board action. Goldman Sachs Group, traded as NYSE:GS, operates as a global investment banking, securities, and asset management firm. Board composition is an important part of how a company like this oversees risk, capital allocation, and long term business priorities. Mittal’s planned...

Telos (TLS) just closed out FY 2025 with Q4 revenue of US$46.8 million and a basic EPS loss of US$0.22, capping a year in which trailing twelve month revenue came in at US$164.8 million and EPS on the same basis was a loss of US$0.50. Over recent quarters the company has seen revenue move from US$26.4 million in Q4 2024 to US$30.6 million in Q1 2025, US$36.0 million in Q2, US$51.4 million in Q3, and US$46.8 million in Q4, while quarterly basic EPS losses ranged between US$0.03 and US$0.22...

GPGI, Inc. recently reported full-year 2025 results showing sales of US$59.82 million versus US$420.57 million a year earlier, with its net loss widening to US$136.01 million, and shortly after, Executive Chairman Dave Cote presented at the JPMorgan Industrials Conference 2026 in Washington, D.C. Together with the appointment of experienced capital-markets lawyer David A.P. Marshall as Chief Legal Counsel and Corporate Secretary, these developments give investors fresh insight into GPGI’s...

AMD (NasdaqGS:AMD) announced the Helios rack-scale AI platform through a new collaboration with Celestica. The partnership focuses on open standards based systems designed for large cloud and enterprise AI deployments. Helios targets rack-scale AI infrastructure with advanced networking and standardized configurations to support heavy AI workloads. The collaboration also aims to improve supply chain resiliency and speed up deployment of AI hardware in data centers. For investors watching...

American Airlines Group (NasdaqGS:AAL) flight attendants have reintroduced protest regalia after a recent no confidence vote in the CEO. The renewed labor actions highlight ongoing tensions between frontline staff and management, raising the prospect of operational and reputational risk. Separately, American Airlines has launched an AAdvantage gift card platform that allows members to use miles for a wider range of everyday purchases. These developments arrive during a period when airlines...

Event driven setup around Flowers Foods Recent commentary around Flowers Foods (FLO) focuses on its large Q4 non cash impairment charge, which has stirred investor skepticism even as some market watchers argue the stock reaction looks harsher than the underlying fundamentals. See our latest analysis for Flowers Foods. At a share price of $8.89, Flowers Foods has seen a 14.2% decline over the past month and a 19.3% decline over the past quarter on a share price return basis. The 1 year total...